Has someone been cured of HIV with a cheap, simple drug regimen?
Islatravir plus doravirine maintains viral suppression for a year
Long-acting capsid inhibitor GS-6207 confirms safety and antiviral activity
HIV vaccine that generates broadly neutralising antibodies passes first safety and proof-of-concept study in humans
Long-acting injectables might be administered every two months
Effectiveness and frequency of dosing are the most important factors affecting acceptability of injectable HIV therapy, says US study
Oral cabotegravir and rilpivirine still effective at 312 weeks
Ibalizumab monoclonal antibody is effective in real-world use
Fostemsavir salvage therapy continues to look good at 96 weeks
